Drugs / HYDROXYPROPYL CELLULOSE
HYDROXYPROPYL CELLULOSE
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | LACRISERT | — | 1981-06-01 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03079271 | Nov 2016 → Jun 2017 | dry eye syndrome | Virginia Eye Consultants | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HYDROXYPROPYL CELLULOSE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201471 ↗ |
| Known as | E463 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201471 ↗ |
| Known as | Lacrisert | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03079271 ↗ |